Industry news

  • 08 December 2014

    Uber for experiments

    The Economist

    A startup enables researchers to tap labs worldwide to conduct experiments on their behalf.

  • 08 December 2014

    Financial incentives and ability to exchange clinical information found to be top reasons for EHR adoption

    The need to share patient information with other providers and the use of financial incentives are key drivers in why many providers adopt and use health information technology tools like electronic health records (EHRs), according a data brief released today from the Office of the National Coordinator for Health IT (ONC).

  • 06 December 2014

    Tragara Reports Interim Results of Phase 1b Study of TG02 and Carfilzomib in Multiple Myeloma

    Tragara Reports Interim Results of Phase 1b Study of TG02 and Carfilzomib in Multiple Myeloma

    TG02 demonstrates ability to mobilize difficult-to-kill leukemic stem cells and render them vulnerable to chemotherapy.

  • 05 December 2014

    Hospital requires use of wireless, wearable sensors to prevent bedsores

    Stacy Lawrence, FierceMedicalDevices

    Chino Valley Medical Center is the first hospital to write a requirement for use of the Leaf Patient Monitoring System to prevent pressure ulcers into its patient safety protocols. The Pleasanton, CA-based, teaching hospital is requiring the use of the adhesive, wireless sensors from Leaf Healthcare to help ensure that its at-risk patients are turned frequently enough by hospital staff to prevent the common problem.

  • 05 December 2014

    23 notable FDA clearances for digital health apps, devices so far this year

    Brian Dolan, Mobi Health News

    MobiHealthNews has been tracking FDA clearances for smartphone-connected medical devices and standalone apps for many years. So far 2014 has had its fair share — about two dozen digital health-related FDA clearances have been secured this year. 

  • 05 December 2014

    Ocular Drug Delivery: Review of Present Technologies and Steps Forward

    ContactPharma

    Market research estimates performed in the last 6 months have shown that the market size for ophthalmic medications is expected to reach more than 25 billion, by the year 2015. The ophthalmology drugs market classification is based on the type of drugs: treatment-based drugs, over-the-counter (OTC) drugs and ocular anesthetics.

  • 05 December 2014

    Report Says Lyo-Market to Reach $4.8B in 2020

    ContactPharma

    According to a new market report by Transparency Market Research, the global lyophilization equipment and services market was valued at $2.7 billion in 2013 and is expected to grow at a CAGR of 8.5% from 2014 to 2020, to reach an estimated value of $4.8 billion in 2020.  

  • 04 December 2014

    CMS: Health spending growth hit record low in 2013

    BioCenture

    CMS's Office of the Actuary said U.S. health spending growth hit a 54-year low of 3.6% in 2013, mirroring a pattern of slow growth in the overall economy over five years. The $2.9 trillion in total health spending represented 17.4% of GDP, which was stable compared to the previous year.

  • 04 December 2014

    New study supports effectiveness of 3-D breast cancer mammography

    Joseph Keenan, FeirceMedicalDevices

    A new study supports the effectiveness of 3-D mammography, which researchers found has the potential to significantly increase the rate of identifying cancer in women with dense breasts who are screened using the digital technology.

  • 04 December 2014

    FDA issues final rule on changes to pregnancy and lactation labeling information for prescription drug and biological products

    U.S. Food and Drug Administration

    The U.S. Food and Drug Administration published a final rule today that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products. The new content and formatting requirements will provide a more consistent way to include relevant information about the risks and benefits of prescription drugs and biological products used during pregnancy and breastfeeding.

All Portfolio

MEDIA CENTER